BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 395674)

  • 1. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
    Surg Forum; 1979; 30():120-1. PubMed ID: 395674
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
    Vogel J; Oehr P; Grouls V
    Pathologe; 1985 May; 6(3):133-40. PubMed ID: 3892526
    [No Abstract]   [Full Text] [Related]  

  • 3. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
    Franc B; Chayvialle JA; Modigliani E; Calmettes C; Caillou B; Dutrieux-Berger N; Houdent C; Kujas M
    Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medullary carcinoma of the thyroid gland. Clinico-pathologic and immunohistochemical study].
    Elsner B; De Marco L; López S; Curutchet HP
    Medicina (B Aires); 1983; 43(3):263-70. PubMed ID: 6369069
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
    Calmettes C; Moukhtar MS; Milhaud G
    Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of calcitonin and carcinoembryonic antigen doubling times in medullary thyroid carcinoma.
    Jackson CE; Norum RA; Talpos GB; Feldkamp CS; Tashjian AH
    Henry Ford Hosp Med J; 1987; 35(2-3):120-1. PubMed ID: 2891643
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinoembryonic antigen as a tissue marker in medullary thyroid carcinoma.
    DeLellis RA; Wolfe HJ; Rule AH
    N Engl J Med; 1978 Nov; 299(19):1082. PubMed ID: 703784
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid tumors.
    Seesko HG; Wells SA
    Immunol Ser; 1990; 53():431-52. PubMed ID: 2100571
    [No Abstract]   [Full Text] [Related]  

  • 13. [Humoral markers in thyroid carcinoma].
    Pinchera A; Pacini F; Martino E; Anelli S
    Minerva Med; 1986 Nov; 77(44):2089-91. PubMed ID: 3785723
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
    Calmettes C; Moudktar MS; Milhaud G
    Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid antibodies.
    Sobrinho-Simões M; Nesland JM; Johannessen JV
    Am J Surg Pathol; 1987 Oct; 11(10):821-4. PubMed ID: 3661825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preoperative cytologic diagnosis of medullary carcinoma of the thyroid].
    Rabitti C; Fadda G; Minimo C; Coronetta F; Russo RM; Capelli A
    Pathologica; 1989; 81(1072):171-7. PubMed ID: 2570396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers in differentiated thyroid carcinoma, excluding medullary carcinoma].
    de Cremoux P; Izembart M; Durand D; Vallee G
    Presse Med; 1984 Jun; 13(24):1515. PubMed ID: 6234530
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of synthesis of carcinoembryonic antigen and calcitonin in patients with medullary carcinoma of the thyroid (author's transl)].
    Ishikawa N
    Kaku Igaku; 1979 Feb; 16(1):29-35. PubMed ID: 439489
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
    Mendelsohn G; Wells SA; Baylin SB
    Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.